FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4282983229> ?p ?o ?g. }

• W4282983229 endingPage "5544" @default.
• W4282983229 startingPage "5544" @default.
• W4282983229 abstract "Abstract Introduction: IL10 is a pleiotropic cytokine that is secreted as a homodimer and initiates signaling on various cell types by engaging two copies of a heterodimeric receptor complex consisting of an IL-10Rα subunit and a IL-10Rβ subunit. IL10 signaling through the natural ligand has both immunosuppressive and immunostimulatory effects and this pleiotropy makes it difficult to develop wild type IL-10 for therapeutic use. In clinical trials that have studied IL10 in cancer, anemia, thrombocytopenia and hemophagocytosis associated with macrophage activation led to dose interruption and dose reduction. To drive more selective cytokine signaling only on cells of interest, we have generated surrogate cytokine agonists that bind to IL10Rα and IL2Rγ, resulting in the selective activation of T cells over macrophages. We establish a novel means of bridging the IL10Rα and IL2Rγ receptors using a IL10Rα/IL2Rγ surrogate cytokine agonist that consists of a domain that binds to IL10Rα and a second domain that binds to IL2Rγ. Upon contact with a cell that allows bridging of IL10Rα and IL2Rγ, the surrogate cytokine agonist causes the functional association of IL10Rα and IL2Rγ, resulting in downstream signaling in select cell types. Experimental Procedures: Human IL-10Rα and IL-2Ry specific single domain VHHs were generated by camel immunization and screening of VHH libraries prepared from peripheral blood cells for binding. Seven IL-10Rα VHHs and six IL-2Ry VHHs were identified and coupled as IL10Rα/IL2Ry dual VHHs in an all by all matrix and in both amino-carboxy and carboxy-amino orientations, yielding 84 unique surrogate cytokine agonists. These surrogate cytokine agonists were screened on a (p)STAT3 assay on primary human cells and further tested in T cell and monocyte functional assays. Results: Several IL10Rα/IL2Rγ surrogate cytokine agonists were biologically active on primary human lymphoid cells, inducing (p)STAT3 signal in B cells, NK cells, CD4 and CD8 T cells with little to no (p)STAT3 signal in monocytes. These IL10Rα/IL2Rγ surrogate cytokine agonists were also functionally active in promoting cell survival and at inducing IFN-γ and Granzyme production by CD8 T cell blasts generated upon CD3/CD28 activation. Consistent with the lack of STAT3 signaling in monocytes, the IL10Rα/IL2Rγ surrogate cytokine agonists did not inhibit LPS induced secretion of IL1β and TNFα by monocytes, suggesting selectivity and a lack of immunosuppressive activities. Conclusions: Designing surrogate cytokine agonists that pair non-natural cytokine receptors provides the possibility of generating molecules that can decouple the pleiotropy of cytokines like IL10 by stimulating only the desired cell population. Here, we have generated IL10Rα/IL2Rγ surrogate cytokine agonists that are biologically active and signal with varying strengths in the lymphoid cells with little to no activity on monocytes, thus providing an opportunity to decouple the pleiotropy of IL10 for use in cancer therapy. Citation Format: Mahalakshmi Ramadass, Sandro Vivona, Deepti Rokkam, Heiko Greb, Anu Gangopadhyay, Romina Riener, Rene de Waal Malefyt, Patrick Lupardus, Martin Oft, Robert Kastelein. IL10/IL2 surrogate cytokine agonists [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 5544." @default.
• W4282983229 created "2022-06-17" @default.
• W4282983229 creator A5000219144 @default.
• W4282983229 creator A5001217519 @default.
• W4282983229 creator A5004108799 @default.
• W4282983229 creator A5018250332 @default.
• W4282983229 creator A5021268908 @default.
• W4282983229 creator A5022698692 @default.
• W4282983229 creator A5023283844 @default.
• W4282983229 creator A5051487266 @default.
• W4282983229 creator A5056295808 @default.
• W4282983229 creator A5087437620 @default.
• W4282983229 date "2022-06-15" @default.
• W4282983229 modified "2023-10-16" @default.
• W4282983229 title "Abstract 5544: IL10/IL2 surrogate cytokine agonists" @default.
• W4282983229 doi "https://doi.org/10.1158/1538-7445.am2022-5544" @default.
• W4282983229 hasPublicationYear "2022" @default.
• W4282983229 type Work @default.
• W4282983229 citedByCount "1" @default.
• W4282983229 countsByYear W42829832292022 @default.
• W4282983229 crossrefType "journal-article" @default.
• W4282983229 hasAuthorship W4282983229A5000219144 @default.
• W4282983229 hasAuthorship W4282983229A5001217519 @default.
• W4282983229 hasAuthorship W4282983229A5004108799 @default.
• W4282983229 hasAuthorship W4282983229A5018250332 @default.
• W4282983229 hasAuthorship W4282983229A5021268908 @default.
• W4282983229 hasAuthorship W4282983229A5022698692 @default.
• W4282983229 hasAuthorship W4282983229A5023283844 @default.
• W4282983229 hasAuthorship W4282983229A5051487266 @default.
• W4282983229 hasAuthorship W4282983229A5056295808 @default.
• W4282983229 hasAuthorship W4282983229A5087437620 @default.
• W4282983229 hasConcept C170493617 @default.
• W4282983229 hasConcept C187316574 @default.
• W4282983229 hasConcept C203014093 @default.
• W4282983229 hasConcept C2775855021 @default.
• W4282983229 hasConcept C2778690821 @default.
• W4282983229 hasConcept C55493867 @default.
• W4282983229 hasConcept C86803240 @default.
• W4282983229 hasConcept C95444343 @default.
• W4282983229 hasConceptScore W4282983229C170493617 @default.
• W4282983229 hasConceptScore W4282983229C187316574 @default.
• W4282983229 hasConceptScore W4282983229C203014093 @default.
• W4282983229 hasConceptScore W4282983229C2775855021 @default.
• W4282983229 hasConceptScore W4282983229C2778690821 @default.
• W4282983229 hasConceptScore W4282983229C55493867 @default.
• W4282983229 hasConceptScore W4282983229C86803240 @default.
• W4282983229 hasConceptScore W4282983229C95444343 @default.
• W4282983229 hasIssue "12_Supplement" @default.
• W4282983229 hasLocation W42829832291 @default.
• W4282983229 hasOpenAccess W4282983229 @default.
• W4282983229 hasPrimaryLocation W42829832291 @default.
• W4282983229 hasRelatedWork W1136917250 @default.
• W4282983229 hasRelatedWork W1976738062 @default.
• W4282983229 hasRelatedWork W2024090141 @default.
• W4282983229 hasRelatedWork W2026456463 @default.
• W4282983229 hasRelatedWork W2059919089 @default.
• W4282983229 hasRelatedWork W2104974169 @default.
• W4282983229 hasRelatedWork W2406295010 @default.
• W4282983229 hasRelatedWork W2414552449 @default.
• W4282983229 hasRelatedWork W2418262148 @default.
• W4282983229 hasRelatedWork W2429602544 @default.
• W4282983229 hasVolume "82" @default.
• W4282983229 isParatext "false" @default.
• W4282983229 isRetracted "false" @default.
• W4282983229 workType "article" @default.